Veyong Pharma akabata makwikwi eCustomer Comment

Kuti vakurudzire zviri nani kupararira kwehombodo yemagariro emakambani, kusimudzira ruzivo rwekushanda kwesimba uye nekuvandudza ruzivo rwemagariro, kurukurai uye kuita tsika nemagariro mumwoyo uye nekunze mukuita. Nekubvumidzwa kwevatungamiriri veboka, kuronga uye kuita zvepamhepo kudzidza uye kuongorora tsika dzekambani mukati memakambani eboka.

Pamasikati aJuly 6th, veyong Pharma akabata makwikwi eCustomer ruzivo rwemakwikwi e "tsika inotungamira rusaruro rwekutanga, uye inotarisa pakugadzira chiratidzo". VAKAWANDA vanomanikidzwa 21 kubva pamapoka manomwe kubva kumashopu akasiyana nemadhipatimendi vakapinda mune chiitiko. Makwikwi eruzivo aive akanyanya uye akararama uye anonakidza, ayo anonyatso kushamwaridzana kwemunhu wese uye kutanga mukudzidza. Munhanho inotevera, kambani inozoita kuti pfungwa yetsika yemakambani, vangairwazve vanhu, vanhu vanodziya netsika, uye vanounganidza vanhu netsika; Rega tsika yemagakama ipe simba rakasimba remweya uye rutsigiro rwetsika rwekukura kwekambani yepamusoro.

Veyony Adheles kune iyo nzira yekuvandudza ye "Kusanganisa yakazvimirira R & D, kushandira pamwe neTekinoroji uye kusimudzira zvigadzirwa zvitsva kuti vape vatengi vane mishonga inoshanda.

Veyong inotora "kuve nehunyanzvi muBiotechnology, sechiitiko chemhando yepamusoro" sechiitiko, chinonyanya kukosha kuve hwakakosha hweveterinary brandIvermectin, Tiamuluin hydrogen fumarate, Oxecetracycline hydrochlorideuye gadziriro.